TMCnet News
2016 U.S. Critical Care Diagnostic Testing in Ancillary Hospital Locations - ER, OR, ICU - Research and MarketsResearch and Markets (http://www.researchandmarkets.com/research/76pq5g/2016_u_s) has announced the addition of the "2016 U.S. Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies" report to their offering. This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products supplier develop more effective business, R&D and marketing strategies. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient. Competitive Assessments - Abbott - ADI/American Diagnostica/Sekisui - Agilent (News - Alert) Technologies - Alere/Biosite/Inverness - Axis-Shield - Beckman Coulter/Danaher - Becton Dickinson - Bio/Data - Biomerieux - Bio-Rad - Cepheid - Chrono-Log - Corgenix - Decode Genetics - Diadexus - Diagnocure - Diagnostica Stago/Trinity Biotech - Diamedix - Diasorin - Eiken Chemical - EKF Diagnostics - Fujirebio - Grifols - Helena Laboratories - Hologic/Gen-Probe - Horiba - Ortho-Clinical Diagnostics - Polartechnics - Polymedco - Qiagen - Roche - SDIX - Sequenom - Sysmex For more information visit http://www.researchandmarkets.com/research/76pq5g/2016_u_s
View source version on businesswire.com: http://www.businesswire.com/news/home/20160203006132/en/ |
